Assertio Holdings, Inc. (ASRT) announced the appointment of Brendan O'Grady as chief executive officer and board member, effective May 29, 2024.
O'Grady, is a seasoned healthcare executive with over 30 years of experience, and previously served as CEO of the Global Formulations business at Glenmark Pharmaceuticals.
The company also said that Heather Mason, the Interim CEO, will return to her position as an independent director.
For comments and feedback contact: editorial@rttnews.com
Business News
May 01, 2026 15:54 ET Central banks dominated the economics news flow this week with almost all major ones announcing their latest policy decisions and many boosted expectations for a rate hike in June. In other news, several countries released the preliminary data for first quarter economic growth. In the U.S., comments by Fed Chair Jerome Powell were also in focus as his term ends this month.